Physician
Tennessee Valley Pediatric Associatesinc.
Tennessee Valley Pediatric Associatesinc. was paid $20.79M by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.
33Billing provider infoTENNESSEE VALLEY PEDIATRIC ASSOCIATESINC.
TUSCUMBIA, AL 35674
TUSCUMBIA, AL 35674
33aNPI1043323439assigned 08/17/2006
33bProvider typePediatrics Physician
28Total paid$20.79M
24GClaims510,491
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Alabama
Rank by total paid#8 of 199
Median peer was paid$702K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 62,734 | $2.31M | |
| 2019 | 70,339 | $2.57M | |
| 2020 | 57,330 | $2.21M | |
| 2021 | 82,532 | $3.45M | |
| 2022 | 84,301 | $3.46M | |
| 2023 | 84,254 | $3.31M | |
| 2024incomplete | 69,001 | $3.49M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 95,477 | 88,737 | $7.93M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 74,159 | 68,423 | $4.01M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.1% | 4,184 | 4,023 | $857K |
| 87428 | 3.8% | 16,902 | 14,976 | $782K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.6% | 12,985 | 12,635 | $751K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.2% | 11,758 | 11,488 | $674K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 25,186 | 23,404 | $519K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.5% | 40,471 | 37,699 | $516K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.4% | 18,933 | 17,829 | $507K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.4% | 8,530 | 8,329 | $491K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.7% | 3,054 | 2,877 | $354K |
| 90670 | 1.3% | 9,962 | 9,807 | $279K |
72 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,363 | $202K |
| 90648 | <1% | 10,670 | $198K | |
| 99223 | Prolong inpt eval add15 m | <1% | 1,097 | $188K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,959 | $184K |
| 90723 | <1% | 7,887 | $167K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,315 | $145K |
| 87807 | <1% | 12,054 | $128K | |
| 90680 | <1% | 6,035 | $125K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,773 | $111K |
| 90633 | <1% | 5,375 | $105K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,619 | $98K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,844 | $98K |
| 90461 | <1% | 1,882 | $96K | |
| 99173 | <1% | 22,746 | $89K | |
| 92551 | <1% | 19,393 | $87K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,267 | $85K |
| 90686 | <1% | 4,232 | $82K | |
| 90651 | <1% | 2,970 | $77K | |
| 90734 | <1% | 2,751 | $70K | |
| 90716 | <1% | 2,491 | $65K | |
| 90707 | <1% | 2,455 | $54K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,749 | $54K |
| 90671 | <1% | 1,646 | $50K | |
| 90696 | <1% | 2,108 | $42K | |
| 90710 | <1% | 2,130 | $41K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,410 | $41K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,278 | $40K |
| 90700 | <1% | 2,058 | $40K | |
| 99460 | <1% | 468 | $40K | |
| 96127 | <1% | 13,643 | $38K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,571 | $31K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 725 | $30K |
| 90715 | <1% | 1,518 | $30K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,095 | $20K |
| 81002 | <1% | 6,755 | $19K | |
| 99051 | <1% | 1,232 | $18K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,291 | $14K |
| 90647 | <1% | 702 | $13K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,520 | $13K |
| 90621 | <1% | 673 | $13K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 254 | $13K |
| 36416 | <1% | 3,359 | $8K | |
| 85018 | <1% | 2,576 | $7K | |
| 90685 | <1% | 362 | $7K | |
| 90681 | <1% | 308 | $6K | |
| 99177 | <1% | 464 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 168 | $5K |
| 90620 | <1% | 233 | $4K | |
| 74018 | <1% | 206 | $4K | |
| 90688 | <1% | 193 | $4K | |
| 69210 | <1% | 122 | $3K | |
| 96161 | <1% | 1,012 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,550 | $3K |
| 90687 | <1% | 143 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 27 | $2K |
| 99000 | <1% | 1,873 | $2K | |
| 90656 | <1% | 99 | $2K | |
| 86328 | <1% | 43 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 13 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 65 | $924.80 |
| 94760 | <1% | 286 | $896.31 | |
| 51701 | <1% | 14 | $798.00 | |
| 17110 | <1% | 12 | $756.00 | |
| 99462 | <1% | 17 | $567.00 | |
| 94010 | <1% | 24 | $441.60 | |
| 82947 | <1% | 108 | $416.79 | |
| 81025 | <1% | 92 | $257.60 | |
| 90785 | <1% | 176 | $164.45 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 86 | $79.68 |
| 71020 | 0% | 29 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 13 | $0.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 213 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSOMERS, KARMEN (ADMINISTRATOR)